Eli Lilly settles whistleblower lawsuit over manufacturing problems Ruchika Sharma1 Oct 2023 4:30 PM ISTUnited States: Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out...
US judge overturns Eli Lilly USD 176.5 million loss in Teva patent case Ruchika Sharma27 Sept 2023 12:45 PM ISTDrugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that...
Eli Lilly-Boehringer Ingelheim Jardiance gets USFDA approval for adults with chronic kidney disease Ruchika Sharma23 Sept 2023 12:30 PM ISTRidgefield: Eli Lilly and Company and Boehringer Ingelheim have announced that the U.S. Food and Drug Administration (FDA) has approved Jardiance...
Eli Lilly Gets CDSCO Panel Nod To Study Rheumatoid Drug LY3871801 Dr. Divya Colin15 Sept 2023 6:00 PM ISTNew Phase: Pharmaceutical major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly Gets CDSCO Panel Nod To Conduct Phase IV CT of Lyumjev Dr. Divya Colin14 Sept 2023 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly diabetes drug Mounjaro won UK watchdog backing: Bloomberg Ruchika Sharma8 Sept 2023 12:34 PM ISTBritain: Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News reported...
Europe to face shortage of Eli Lilly diabetes drug Trulicity through September Ruchika Sharma30 Aug 2023 11:30 AM ISTEurope: Europe will continue to face a shortage of Eli Lilly & Co's blockbuster diabetes drug Trulicity through September, the European Medicines...
Retevmo demonstrates superior progression free survival compared to approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer: Eli Lilly Ruchika Sharma23 Aug 2023 12:30 PM ISTRetevmo is a highly selective and potent RET kinase inhibitor with CNS activity.
Eli Lilly concludes acquisition of Versanis Bio Ruchika Sharma18 Aug 2023 5:14 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Versanis Bio. The acquisition expands...
Eli Lilly concludes acquisition of Sigilon Therapeutics Ruchika Sharma17 Aug 2023 10:00 AM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. The acquisition...
Eli Lilly concludes acquisition of DICE Therapeutics Ruchika Sharma12 Aug 2023 2:30 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of DICE Therapeutics, Inc.. The acquisition...
Eli Lilly sued by Nektar Therapeutics over autoimmune disease treatment Ruchika Sharma8 Aug 2023 1:30 PM ISTUS: Nektar Therapeutics has sued Eli Lilly, accusing the U.S. drugmaker of undermining the prospects for a drug the companies were developing...
